; Vermillion, Inc. (VRML) - Product Pipeline Analysis
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

Vermillion, Inc. (VRML) - Product Pipeline Analysis

VIEWS: 30 PAGES: 28

Vermillion, Inc. (VRML) - Product Pipeline Analysis Summary This report is a source for data, analysis and actionable intelligence on the Vermillion, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope - Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. - Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. - Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. - Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. - Data on relevant clinical trials and product patent details, wherever applicable. - Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility. Reasons t

More Info
  • pg 1
									                                            Vermillion, Inc. (VRML) - Product Pipeline Analysis

     Reference Code: GDMEPH14906PD                                                                                                 Publication Date: NOV 2010



     Company Snapshot                                                           Company Overview
     Key Information
                                                                                Vermillion, Inc. (VRML) is a pharmaceutical company that discovers,
      Vermillion, Inc., Key Facts                                               develops and commercializes diagnostic tests to improve patient care by
                                                                                physicians. It offers diagnostic products with focus on clinical conditions
      Web Address                             www.vermillion.com
                                                                                like oncology, cardiology and hematology. VRML develops and offers
      Turnover (in USD Million)               0                                 diagnostic tests such as thrombotic thrombocytopenic purpura (TTP) test,
                                                                                peripheral artery disease (PAD) blood test, and ovarian tumor triage test,
      Number of Employees                     2                                 ovarian cancer high-risk triage test, ovarian cancer prognosis test for
      Industry                                Pharmaceuticals and Healthcare-   thrombotic thrombocytopenic purpura (TTP), peripheral artery disease
      Source:Primary / Secondary Research                                       (PAD), and ovarian cancer.
      GlobalData




     Vermillion, Inc. Pipeline Products

      Vermillion, Inc. Key Pipeline Products by Equipment Type                  Vermillion, Inc. Key Pipeline Products by Therapy Area

     Equipment Type                                         No of Products      Therapy Area                                            No of Products
     Immuno Chemistry                                              5            Alzheimer’s disease                                            1
     Source: Primary / Secondary Research                                       Breast cancer                                                   1
     GlobalData
                                                                                Ovarian cancer                                                  1
                                                                                Peripheral arterial disease                                     1
                                                                                Prostate cancer                                                 1
                                                                                Source: Primary / Secondary Research
                                                                                GlobalData




      Vermillion, Inc. Key Pipeline Products by Development Stage

     Developmental Stage                                                                                          No of Products
     Clinicals                                                                                                           4
     Pre-Clinicals                                                                                                      -
     Early development                                                                                                  1
     Source: Primary / Secondary Research
     GlobalData
     Note : (-) indicates 'Not Available'



      Vermillion, Inc. Key Pipeline Products by Trial Phase

     Trial Phase                                                                                                  No of Products
     Phase IV                                                                                                           -
     Phase III                                                                                                          -
     Phase II                                                                                                           -
     Phase I                                                                                                            -
     Source: Primary / Secondary Research
     GlobalData
     Note : (-) indicates 'Not Available'




Vermillion, Inc. (VRML) - Product Pipeline Analysis                                                                                 Reference Code: GDMEPH14906PD

Source : www.globalcompanyintelligence.com                                                                                                                      Page 1
     Table of Contents
     Table of Contents................................................................................................................................................................................................................................................................... 2
     List of Tables .......................................................................................................................................................................................................................................................................... 3
     List of Figures......................................................................................................................................................................................................................................................................... 3
     Vermillion, Inc. - Business Description................................................................................................................................................................................................................................... 4
     Key Facts ............................................................................................................................................................................................................................................................................... 5
     Vermillion, Inc. - Major Products and Services ...................................................................................................................................................................................................................... 6
           Vermillion, Inc. Pipeline Products by Equipment Type .................................................................................................................................................................................................... 7
           Vermillion, Inc. Pipeline Products by Development Stage............................................................................................................................................................................................... 9
           Vermillion, Inc. Pipeline Products by Therapy Area ...................................................................................................................................................................................................... 11
           Vermillion, Inc. Pipeline Products by Milestone Summary ............................................................................................................................................................................................ 14
           Alzheimer's Disease Diagnostic Assay.......................................................................................................................................................................................................................... 16
                 Product Status......................................................................................................................................................................................................................................................... 16
                 Product Description ................................................................................................................................................................................................................................................. 16
           Biomarkers For Breast Cancer ...................................................................................................................................................................................................................................... 16
                 Product Status......................................................................................................................................................................................................................................................... 16
                 Product Description ................................................................................................................................................................................................................................................. 16
                 Product Institution Details ....................................................................................................................................................................................................................................... 16
           Biomarkers For Ovarian Cancer .................................................................................................................................................................................................................................... 17
                 Product Status......................................................................................................................................................................................................................................................... 17
                 Product Description ................................................................................................................................................................................................................................................. 17
                 Product Milestone ...........................................................................................................................
								
To top